Susquehanna International Group, LLP Iveric Bio, Inc. Put Options Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 11, 2023	SELL	$26.24 - $39.63 $2.35 Million - $3.54 Million	-89,400 Reduced 25.28%	264,200 $10.4 Million
Q1 2023 May 16, 2023	BUY	$18.67 - $24.56 $2.94 Million - $3.87 Million	157,400 Added 80.22%	353,600 $8.6 Million
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $2.78 Million - $3.87 Million	-161,500 Reduced 45.15%	196,200 $4.2 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $882,660 - $1.75 Million	93,900 Added 35.6%	357,700 $6.42 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.